Whitepapers

Multiple sclerosis therapy has been transformed by agents that control inflammation, and the unmet need has shifted...

The FDA issued draft guidance on the development of non-opioid analgesics for acute pain in 2022, covering development...

The GLP-1 receptor agonists have changed the trajectory of type 2 diabetes care, and the evidence now suggests their...

Postoperative pain management is in the middle of a reimbursement shift. Since January 2025, Medicare has paid...

Diabetic peripheral neuropathy affects nearly half of people living with diabetes, and it remains one of the harder...